AdAlta Limited (1AD.AX)
ASX - ASX Delayed Price. Currency in AUD
Add to watchlist
As of 10:00AM AEST. Market open.
| Previous Close | 0.0260 |
| Open | 0.0260 |
| Bid | 0.0260 x 25215400 |
| Ask | 0.0270 x 5549800 |
| Day's Range | 0.0260 - 0.0260 |
| 52 Week Range | 0.0170 - 0.0480 |
| Volume | |
| Avg. Volume | 2,860,548 |
| Market Cap | 13.848M |
| Beta (5Y Monthly) | 0.72 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | Feb 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.AdAlta Insiders Placed Bullish Bets Worth AU$850.2k
It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it...
- Simply Wall St.
It's Probably Less Likely That AdAlta Limited's (ASX:1AD) CEO Will See A Huge Pay Rise This Year
Key Insights AdAlta's Annual General Meeting to take place on 22nd of November Salary of AU$324.9k is part of CEO Tim...
- Newsfile
AdAlta to Present at August 24th Virtual Investor Summit
Melbourne, Australia--(Newsfile Corp. - August 16, 2023) - AdAlta Limited (ASX: 1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be presenting at the Virtual Investor Summit on 24 August, hosted by Investor Summit Group.During his presentation at the Summit, Dr Oldham will describe the products that AdAlta is developing to treat challenging diseases such as ...
© 2024 Yahoo. All rights reserved.